Navigation Links
Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
Date:10/1/2007

- Former Research Team Director and Key Strategy Architect to Build on

Foundation's Momentum In Pursuing Systemic Changes to Advance in

Parkinson's Disease Treatments -

NEW YORK, Oct. 1 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation for Parkinson's Research (MJFF) today announced that Katie Hood, Deputy Chief Executive Officer and former Research Director, has been appointed Interim Chief Executive Officer. Ms. Hood, who joined the Foundation in September 2002, has played critical roles in shaping its strategy of intervening aggressively to close critical gaps in the process of moving potential treatments from the laboratory to Parkinson's patients, as well as in building a team of in-house research experts needed to implement that strategy.

Ms. Hood replaces CEO Sarah Orsay, who is leaving MJFF in order to devote more time to her three children.

MJFF Founder Michael J. Fox said, "The Michael J. Fox Foundation has grown enormously in our sophistication and in our capability to work with everyone from academic researchers to industry in plugging the many gaps in the process that keep promising science from advancing to effective, life-changing treatments for Parkinson's. Katie Hood has played a big part in that evolution, and we're confident that with her at the helm, we will not only maintain our momentum but will continue to build our reputation for not just throwing money at the problem, but truly taking a leadership role in helping identify and cultivate research breakthroughs."

Ms. Hood stated, "After five years working with management and staff at all levels of MJFF, as well as our scientific advisors, grantees, industry partners and donors, I am looking forward to working with Michael, our Board and our entire team to further advance the mission and strategy of a foundation that is increasingly setting the standard for effectiveness and best business practices."

As Interim Chief Executive Officer, Ms. Hood will provide day-to-day management and oversight of all Foundation activities and will specifically oversee fundraising, the Foundation's research team and communications, administration and financial management. Ms. Hood will report to the Board of Directors. Debi Brooks will continue to serve as co-founder with a focus on principal-gifts fundraising and outreach to key external audiences, reporting to the Board of Directors.

The Foundation stated that Ms. Hood will be a candidate to assume the CEO position on a permanent basis.

Prior to joining the Foundation, Ms. Hood was employed as a consultant at Bain & Company in New York City, doing work in the consumer products, financial services, and nonprofit sectors. She has also served as an analyst in the Credit Department of Goldman, Sachs & Co., and as a program coordinator with Duke University's Hart Leadership Program. Ms. Hood graduated from Harvard Business School, and holds a BA in Public Policy Studies from Duke University in Durham, North Carolina.

About The Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within this decade through an aggressively funded research agenda. The Foundation has funded more than $95 million in research to date, either directly or through partnerships. For more information please visit the Foundation's Web site at http://www.michaeljfox.org.


'/>"/>
SOURCE Michael J. Fox Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Katee Holmes Vs Katie Holmes Case of Losing Virginity
2. Katie Holmes in most Influential Celebs List
3. Wood Appointed As the First Chair of SAADAT
4. Yoga Guru appointed Bihars brand ambassador
5. Disappointed Students Plan To Intensify Agitation Nationwide
6. City Surgeon Appointed Adviser To Armed Forces
7. Indian-American Appointed for US Hospital Top Post
8. Retiring Government Doctors to Be Reappointed to Overcome Paucity of Specialists
9. Bruce Vladeck Will Hold Fort (interim) of UMDNJ
10. Interim WHO Chief Confirms No radical changes in WHO
11. Interim OPD saves the day for patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Doctor ... announced it attended the January ECRM trade show to continue the marketing and distribution ... vitamin C supplement, known for providing 400 percent better absorption than traditional vitamin C ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Michael and ... Dana Farber Cancer Institute. For Betsy, the clinical trial has been life-saving as ... has not worsened. , Betsy Brauser was diagnosed with ovarian cancer in 2009. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Code Word: Chocolate Biscuit”: a biographical account following ... Chocolate Biscuit” is the creation of published author, Marlyn Ivey, born in Lynn Haven, Florida ... went to school and at 19 years of age, he joined the Navy and got ...
(Date:1/20/2017)... ... ... is God’s Lighthouse”: a moving and colorful collection of prayers that reminds readers ... author, Gene Gaapf, a retired truck driver, and a long-time writer, whose published works ... school and have many different titles,” Gaapf mentions about his different works. “I am ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Next week after ... be repealed by Congressional political games that circumvent health needs of over 30 million. ... capture the human anxieties and needs government public servants were suppose to prioritize. Interviews ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 According to ... for cryotherapy is set to witness a CAGR of 6.5% during ... America will continue to be the leading market for ... ... Suppliers are emphasizing on ensuring affordable and adequate supply of gas ...
(Date:1/19/2017)... Jan. 19, 2017 ViewRay, Inc. (Nasdaq: VRAY) announced ... institution supporting research in Germany , ... treatments at the University Clinic Heidelberg as part of ... MRIdian Linac program will be headed by Medical Director ... radiation oncology at the German Cancer Research Center (DKFZ), ...
(Date:1/19/2017)... BEACH, Florida , January 19, 2017 /PRNewswire/ ... incoming Trump administration appears serious about reducing the ... advancements and innovation in the medical drug industry, ... forge ahead with new clinical trials and development ... Pharma companies forging ahead with recent developments include:  ...
Breaking Medicine Technology: